OverviewSuggest Edit

F-star is a clinical-stage biopharmaceutical company developing bispecific antibody immuno-oncology products selected for their potential to transform the treatment of cancer. Through the application of its highly efficient Modular Antibody Technology™ platform, F-star is the only biotechnology company able to create bispecific antibodies, where the second binding site is in the constant Fc region of an antibody, offering unprecedented ease in the discovery, development and manufacturing of bispecific antibody products. The strength of the technology and programmes has been leveraged through partnerships with leading biopharmaceutical companies including, AbbVie, Bristol-Myers Squibb, Merck Serono and Boehringer Ingelheim.
HQCambridge, GB


F-star Biotechnology is headquartered in
Cambridge, United Kingdom

Location Map

Latest Updates

Employees (est.) (Nov 2020)78(-1%)
Revenue (FY, 2018)£18.7 M(+47%)
Cybersecurity ratingAMore

Key People/Management at F-star Biotechnology

Eliot Forster

Eliot Forster

President & Chief Executive Officer
Nessan Bermingham

Nessan Bermingham

Darlene Deptula-Hicks

Darlene Deptula-Hicks

Chief Financial Officer
Jean-François Formela

Jean-François Formela

Board Member
Patrick Krol

Patrick Krol

Board Member
Deborah Harland

Deborah Harland

Board Member
Show more

F-star Biotechnology Office Locations

F-star Biotechnology has offices in Cambridge and Wien
Cambridge, GB (HQ)
Babraham Research Campus, Eddeva B920
Wien, AT
7 Schwarzenbergpl.
Cambridge, US
245 First St 18th floor
Show all (3)

F-star Biotechnology Financials and Metrics

Summary Metrics

Founding Date


F-star Biotechnology total Funding

$57.3 m

F-star Biotechnology latest funding size

$9.40 m

Time since last funding

7 years ago

F-star Biotechnology investors

F-star Biotechnology's latest funding round in October 2013 was reported to be $9.4 m. In total, F-star Biotechnology has raised $57.3 m
Show all financial metrics

F-star Biotechnology Revenue

F-star Biotechnology's revenue was reported to be £18.70 m in FY, 2018

Revenue (FY, 2018)


Net income (FY, 2018)


EBIT (FY, 2018)


Cash (31-Dec-2018)

GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018



Revenue growth, %


Depreciation and amortization



GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018



Accounts Receivable


Current Assets



GBPFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income


Cash From Operating Activities


Cash From Financing Activities


Net Change in Cash

GBPFY, 2012

Financial Leverage

1.4 x
Show all financial metrics

F-star Biotechnology Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

F-star Biotechnology Online and Social Media Presence

Embed Graph

F-star Biotechnology Frequently Asked Questions

  • When was F-star Biotechnology founded?

    F-star Biotechnology was founded in 2006.

  • Who are F-star Biotechnology key executives?

    F-star Biotechnology's key executives are Eliot Forster, Nessan Bermingham and Darlene Deptula-Hicks.

  • How many employees does F-star Biotechnology have?

    F-star Biotechnology has 78 employees.

  • What is F-star Biotechnology revenue?

    Latest F-star Biotechnology annual revenue is £18.7 m.

  • What is F-star Biotechnology revenue per employee?

    Latest F-star Biotechnology revenue per employee is £239.8 k.

  • Who are F-star Biotechnology competitors?

    Competitors of F-star Biotechnology include Idera Pharmaceuticals, Atopix and Biothera.

  • Where is F-star Biotechnology headquarters?

    F-star Biotechnology headquarters is located at Babraham Research Campus, Eddeva B920, Cambridge.

  • Where are F-star Biotechnology offices?

    F-star Biotechnology has offices in Cambridge and Wien.

  • How many offices does F-star Biotechnology have?

    F-star Biotechnology has 3 offices.